HIF‐1α increases RANKL expression in stromal fibroblasts,(38) breast cancer cells,(39) and osteocytic MLO‐Y4 cells.(40) HIF‐2α deficiency in mice enhances bone mass, in part by inhibiting osteoclastogenesis. This evidence concerns the gene HIF1A and breast cancer.